Global and India Bacteriophage Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Bacteriophage Market Report & Forecast 2024-2034
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Market Analysis and InsightsGlobal and India Bacteriophage Market
This report focuses on global and India Bacteriophage market, also covers the segmentation data of other regions in regional level and county level.
The global Bacteriophage revenue was US$ 37 million in 2024 and is forecast to a readjusted size of US$ 121.4 million by 2034 with a CAGR of 18.8% during the review period (2024-2034).
Global key players of bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top three players hold a share about 23%. North America is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 29% and 23%, separately.
Global Bacteriophage Scope and Market Size
Bacteriophage market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Bacteriophage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Bacteriophage market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Bacteriophage definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Bacteriophage companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Bacteriophage in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacteriophage revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and India Bacteriophage Market
This report focuses on global and India Bacteriophage market, also covers the segmentation data of other regions in regional level and county level.
The global Bacteriophage revenue was US$ 37 million in 2024 and is forecast to a readjusted size of US$ 121.4 million by 2034 with a CAGR of 18.8% during the review period (2024-2034).
Global key players of bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top three players hold a share about 23%. North America is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 29% and 23%, separately.
Global Bacteriophage Scope and Market Size
Bacteriophage market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Bacteriophage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Bacteriophage market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.
By Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Bacteriophage definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Bacteriophage companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Bacteriophage in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacteriophage revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions